Literature DB >> 28922075

Factors associated with optimal antenatal care use in Northern region, Ghana.

Abdulai Abubakari1, Faith Agbozo2, Gilbert Abotisem Abiiro3.   

Abstract

The objective of this study was to investigate the factors associated with the optimal use of antenatal care (ANC) during pregnancy. A facility-based cross-sectional survey was conducted between February and August 2014 among nursing mothers (n = 578) attending postnatal and child welfare clinics in three districts in Northern Ghana, representing urban, peri-urban, and rural zones. The developed questionnaire aided the collection of information on maternal demographic characteristics, health status, household assets, and ANC attendance. Binary logistic regression was modeled to estimate the association between optimal ANC use and mothers' characteristics. Approximately 81% of the respondents had ≥4 ANC visits during pregnancy, and coverage was over 99%. Mothers who had any formal education (adjusted odds ratio [AOR] = 1.7, 95% confidence interval [CI] = 1.0-2.8, P = 0.040) lived in middle class socioeconomic households (AOR = 2.6, 95%CI = 1.4-4.8, P = 0.003) and resided in urban areas (AOR = 2.0, 95%CI = 1.2-3.3, P = 0.006) were significantly more likely to report the optimal ANC use. Mothers' education, socioeconomic status, and proximity to a health facility were positively associated with the optimal ANC use. Education of females and policy initiatives aimed at improving the rural-urban divide are essential to optimize the use of ANC.

Entities:  

Keywords:  Antenatal care; Northern Ghana; pregnancy; socioeconomic

Mesh:

Year:  2017        PMID: 28922075     DOI: 10.1080/03630242.2017.1372842

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  1 in total

1.  Adherence to appointments for gestational diabetes testing and experiences with two-hour postprandial glucose test: a mixed-methods study in Ghana.

Authors:  Faith Agbozo; Christina Schuler; Albrecht Jahn
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-06       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.